Indian pharma exports drop 40% in downturn

The economic downturn in the U.S. has hurt the pharmaceuticals industry worse than any other export sector in the Indian economy. Drug exports dropped almost 40 percent between October 2008 and the end of February 2009 as Indian companies lose relative share to other emerging-market competitors. Report

Suggested Articles

Amgen could soon face new competition in the PCSK9 class, but an efficacy boost in treating high-risk heart attack patients could help keep it ahead.

In its quest to become the dominant SGLT2 diabetes med for heart failure, Jardiance is touting DPP-4 inhibitor-topping data to support its case.

Despite having lost some of its novelty, AZ's Brilinta is touting bleeding data over aspirin that could be a big break in acute coronary syndrome.